Outcomes of hybrid closed-loop insulin delivery activated 24/7 versus evening and night in free-living prepubertal children with type 1 diabetes: A multicentre, randomized clinical trial.
Pr Eric RenardNadia Tubiana-RufiElisabeth BonnemaisonRégis CoutantFabienne Dalla-ValeElise BismuthNathalie FaureNatacha Bouhours-NouetAnne FarretCaroline StoreyAurélie DonzeauAmélie PoidvinJessica Amsellem-JagerJérôme PlaceMarc D Bretonnull nullPublished in: Diabetes, obesity & metabolism (2021)
The current study shows the safety and efficacy of the Tandem Control-IQ system in free-living children with type 1 diabetes for both E/N and 24/7 use; 24/7 use shows better outcomes, sustained for up to 36 weeks with no safety issues.